Animal genetics company Genus (LON:GNS) said that trading in the final two months of the financial year had been in line with expectations and it was on track to achieve an improvement in performance in the second half of the year.
Genus added that it had benefited from exchange rate movements and would report a small non-cash exceptional gain resulting from the closure to future accrual of defined benefit pensions in the Milk Pension Fund.
In a trading statement released in May, Genus reported an increased demand from customers in the North American market, which were looking to update the genetics in their herds as confidence in the strength of the recovery improved. Demand had also been strong in Latin America and China, while trading in Europe was in line with expectations.
Proactiveinvestors is a leading multi-media news organisation, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt and London.
No comments:
Post a Comment